A. J. Kazimi - Jun 13, 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Jun 13, 2024
Transactions value $
$691
Form type
4
Date filed
7/2/2024, 05:31 PM
Previous filing
Mar 26, 2024
Next filing
Aug 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $38.00 +25 +0% $1.52 5.7M Jun 13, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $72.00 +48 +0% $1.50 5.7M Jun 14, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.10 +41 +0% $1.49 5.7M Jun 17, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $64.40 +41 +0% $1.57 5.7M Jun 18, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $62.70 +41 +0% $1.53 5.7M Jun 20, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.10 +41 +0% $1.49 5.7M Jun 21, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $70.00 +44 +0% $1.59 5.7M Jun 24, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $67.80 +44 +0% $1.54 5.7M Jun 25, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66.00 +44 +0% $1.50 5.7M Jun 26, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66.90 +44 +0% $1.52 5.7M Jun 27, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.50 +41 +0% $1.50 5.7M Jun 28, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.